Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problem hepatitis viruses: the mutants

R S Koff1

  • 1Department of Medicine, University of Massachusetts Medical School, MetroWest Medical Center, Framingham 01760-6099.

The American Journal of Medicine
|January 17, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.

Alimentary pharmacology & therapeutics·2014
Same author

Review article: vaccination and viral hepatitis - current status and future prospects.

Alimentary pharmacology & therapeutics·2007
Same author

Prevention of hepatitis C virus infection.

Clinics in liver disease·2004
Same author

Terbinafine-induced hepatitis and pancytopenia.

Digestive diseases and sciences·2001
Same author

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Journal of clinical gastroenterology·2001
Same author

Hepatitis vaccines.

Infectious disease clinics of North America·2001
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Genetic variations in human hepatitis viruses arise from rapid replication and poor proofreading in RNA viruses and reverse transcription in DNA viruses. These genetic changes impact viral behavior and disease, driving research into mutants for vaccines and treatments.

Area of Science:

  • Virology
  • Genetics
  • Immunology

Background:

  • Human hepatitis viruses (HAV, HBV, HCV, HDV, HEV) exhibit genetic variability.
  • RNA viruses (HAV, HCV, HDV, HEV) have high replication rates and limited proofreading.
  • Hepatitis B virus (HBV), a DNA virus, replicates via reverse transcription.

Purpose of the Study:

  • To explore the origins and implications of genetic diversity in human hepatitis viruses.
  • To understand how genetic variations influence viral pathogenicity and host interactions.
  • To highlight the significance of studying viral mutants in clinical and therapeutic contexts.

Main Methods:

  • Analysis of genetic variation mechanisms in RNA and DNA hepatitis viruses.
  • Review of studies on nucleotide substitutions, deletions, duplications, insertions, and rearrangements.

Related Experiment Videos

  • Examination of the functional consequences of genetic mutations.

    • Main Results:

    • Genetic diversity is a characteristic feature of all known human hepatitis viruses.
    • Mutations can result in altered viral replication, host susceptibility, and immune evasion.
    • Specific genetic variations have been identified across HAV, HBV, HCV, HDV, and HEV.

    Conclusions:

    • Understanding hepatitis virus genetic diversity is crucial for addressing pathogenicity and disease progression.
    • Viral mutants play a significant role in immune response, clinical outcomes, and treatment efficacy.
    • Further intensive research on viral genetic variations is essential for developing effective vaccines and therapies.